These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23231397)

  • 1. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review.
    Koyiparambath VP; Prayaga Rajappan K; Rangarajan TM; Al-Sehemi AG; Pannipara M; Bhaskar V; Nair AS; Sudevan ST; Kumar S; Mathew B
    Chem Biol Drug Des; 2021 Oct; 98(4):655-673. PubMed ID: 34233082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
    Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
    Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
    Costas-Lago MC; Besada P; Rodríguez-Enríquez F; Viña D; Vilar S; Uriarte E; Borges F; Terán C
    Eur J Med Chem; 2017 Oct; 139():1-11. PubMed ID: 28797881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
    Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkynyl-coumarinyl ethers as MAO-B inhibitors.
    Mertens MD; Hinz S; Müller CE; Gütschow M
    Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors.
    Secci D; Carradori S; Bolasco A; Bizzarri B; D'Ascenzio M; Maccioni E
    Curr Top Med Chem; 2012; 12(20):2240-57. PubMed ID: 23276158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
    Fonseca A; Reis J; Silva T; Matos MJ; Bagetta D; Ortuso F; Alcaro S; Uriarte E; Borges F
    J Med Chem; 2017 Aug; 60(16):7206-7212. PubMed ID: 28753307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
    Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
    J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.
    Viña D; Matos MJ; Ferino G; Cadoni E; Laguna R; Borges F; Uriarte E; Santana L
    ChemMedChem; 2012 Mar; 7(3):464-70. PubMed ID: 22287164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
    Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
    J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
    He X; Chen YY; Shi JB; Tang WJ; Pan ZX; Dong ZQ; Song BA; Li J; Liu XH
    Bioorg Med Chem; 2014 Jul; 22(14):3732-8. PubMed ID: 24856304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Quezada E; Picciau C; Delogu G; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3268-70. PubMed ID: 19423346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
    Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
    J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.